Sort
10,766 grants matching “checkpoint inhibitor”
SPORE In Prostate Cancer
$2,185,002William George Nelson · Johns Hopkins University · P50 · FY2011 · CA
DF/HCC Kidney Cancer SPORE
$2,185,000David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2015 · CA
UCLA SPORE in Brain Cancer
$2,185,000Linda M Liau · University Of California Los Angeles · P50 · FY2017 · CA
SPORE in Myeloid Malignancies
$2,185,000Benjamin Levine Ebert · Brigham And Women'S Hospital · P50 · FY2017 · CA
UCLA SPORE in Brain Cancer
$2,185,000Linda M Liau · University Of California Los Angeles · P50 · FY2020 · CA
SPORE in Bladder Cancer
$2,184,846Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
SPORE in Breast Cancer
$2,181,491Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2023 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,179,298Barbara Burtness · Yale University · P50 · FY2024 · DE
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,173,410James Brugarolas · Ut Southwestern Medical Center · P50 · FY2022 · CA
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,173,408James Brugarolas · Ut Southwestern Medical Center · P50 · FY2023 · CA
SPORE in Brain Cancer
$2,171,252Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
University of Wisconsin Prostate SPORE
$2,167,946David F Jarrard · University Of Wisconsin-Madison · P50 · FY2025 · CA
HCC Ovarian Cancer SPORE
$2,165,016Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
$2,164,833Haian Fu · Emory University · P01 · FY2023 · CA
HCC Ovarian Cancer SPORE
$2,163,827Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Brain Tumor Clinical and Clinical Research Program
$2,162,361Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2017 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,156,230Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
DF/HCC Kidney Cancer SPORE
$2,156,131David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2016 · CA
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,156,021Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2022 · CA
SPORE in Breast Cancer
$2,153,378Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,149,233Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,148,642Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,147,606Peter Karl Sorger · Harvard Medical School · U54 · FY2018 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$2,147,209Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$2,144,148Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA